Galapagos NV : - Transparency notification received from The Capital Group

Belgium - Galapagos NV (Euronext & NASDAQ: GLPG) received a new transparency notification from The Capital Group Companies, Inc.

Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on 26 February 2021 from The Capital Group Companies, Inc., who notified that it holds 9.91% of the current 65,411,767 outstanding Galapagos shares. The Capital Group Companies, Inc. thus crossed below the 10% threshold of Galapagos' voting rights by disposing of voting securities on 22 February 2021. The full transparency notice is available on the Galapagos website.

About Capital Group

Capital Group controls Capital Bank & Trust Company and Capital Research & Management Company through its direct subsidiary Capital Group International, Inc. ('CGII'), controls four CGII investment management companies (Capital International, Inc.; Capital International Limited, Capital International Sarl and Capital International K.K.), which all together hold 6,483,973 of Galapagos' voting rights, consisting of ordinary shares, which represents 9.91%.

About Galapagos

Galapagos NV discovers and develops small molecule medicines with novel modes of action, several of which show promising patient results and are currently in late-stage development in multiple diseases. Our pipeline comprises Phase 3 through to discovery programs in inflammation, fibrosis, and other indications. Our ambition is to become a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines.

Contact:

Elizabeth Goodwin

Tel: [phone]

(C) 2021 Electronic News Publishing, source ENP Newswire